SCHEMBL7865482

SCHEMBL7865482

CCC(CN)CCP(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
S1PR2 O95136 5/20 0.44
S1PR1 P21453 5/20 0.44
S1PR3 Q99500 5/20 0.44
S1PR4 O95977 4/20 0.44
LAP3 P28838 1/20 0.43
ENPEP Q07075 1/20 0.42
ANPEP P15144 2/20 0.39
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
NFKB1 P19838 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
ERAP2 Q6P179 1/20 0.39
FDPS P14324 1/20 0.38
METAP1 P53582 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27650676 0.77 GABBR2 (0.50) ALDH1A1TDP1LAP3ANPEPLMNA
Phosphoric Acid SCHEMBL1882364 0.77 ALDH1A1 (0.75) ALDH1A1TDP1LAP3CYP3A4FDPS
Phosphoric Acid SCHEMBL1882365 0.77 ALDH1A1 (0.75) ALDH1A1TDP1LAP3CYP3A4FDPS
SCHEMBL242286 0.75 ENPEP (0.50) ALDH1A1TDP1S1PR2S1PR1S1PR3
SCHEMBL20395046 0.74 LAP3 (0.39) ALDH1A1TDP1S1PR2S1PR1S1PR3
SCHEMBL17687466 0.74 S1PR2 (0.62) S1PR2S1PR1S1PR3S1PR4LAP3
SCHEMBL6412081 0.73 ALDH1A1 (0.50) ALDH1A1TDP1S1PR2S1PR1S1PR3
SCHEMBL5059525 0.73 S1PR1 (0.62) ALDH1A1TDP1S1PR2S1PR1S1PR3
SCHEMBL16241036 0.72 ALDH1A1 (0.68) ALDH1A1TDP1CYP3A4
SCHEMBL30825877 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100487-A2 COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN-ASSOCIATED MOLECULAR INTERACTIONS Neurochem, Inc. (CA) 2001-05-23 EP disclosed
WO-2000006133-A2 COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN-ASSOCIATED MOLECULAR INTERACTIONS NEUROCHEM, INC. (CA) 2000-02-10 WO disclosed